INDIANAPOLIS - As the prevalence of diabetes increases, Eli Lilly and Company is making strides to improve the availability of care to patients.
Lilly is increasing its insulin manufacturing capacity and adding two new insulin-cartridge-filling lines to the Indianapolis facility. Those cartridges can be used in insulin pens, which are growing in popularity.
Operations manager for filling, Lyle Fait, said the filling lines will pump 600 cartridge units a minute.
"With diabetes worldwide becoming almost epidemic in terms of the magnitude, this is the supply and demand that we are trying to meet in terms of keeping the global market supplied," Fait said.
Lilly is a global leader in the treatment of diabetes. The company introduced insulin as a treatment in 1923.
Officials said $400 million was being poured into the facilities, which will further Lilly’s pursuit of offering a full range of innovative options to diabetics.
National diabetes statistics show nearly 25.8 million people in the United States have diabetes. As many of seven million of those people are undiagnosed.
School works to honor boys, mom killed in crash
It’s been a tough first month back for Center Grove students. Two of their fellow students – Aidan and Branson Buck – were…
Woman's body found in rural Hancock County
Hancock County authorities were investigating Thursday after a woman's body was found near Jacob Schramm Nature Preserve.
Watch the Colts on Monday Night Football on RTV6
Are you ready for some football on RTV6?
Marion Co. reports first human case of West Nile
Marion County reported its first human case of West Nile Virus for 2015 this week.
Josh McNary found not guilty on all charges
Ex-Colts linebacker Josh McNary has been found not guilty on all charges in his rape trial.